In 2019, Boehringer Ingelheim has sponsored the annual European PRRS Research Award for the sixth time already.
The company will invest 200 million euro into this high-tech complex, located near Lyon, France, and create around 100 skilled jobs.
The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools to maintain and enhance animal health.
It is the first comprehensive ‘industry-academia-research’ exchange platform jointly set up by an agricultural research institute and a multinational animal health company in China.
Boehringer Ingelheim plans a pilot programme using the innovative SoundTalksTM system in select pig barns. The goal is to harness the power of digital innovation and technological change to detect possible respiratory distress in swine quickly
This sale is part of Boehringer Ingelheim Animal Health’s strategic refocusing on advanced and preventive animal healthcare; Saint-Herblon mainly producing generics and antibiotics for livestock, under the Coophavet brand.
The first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine market.
This tool enables pig producers to evaluate areas for biosecurity improvement on their farms.
Dopharma is a growing player on the market, already distributing in more than 50 countries.
The new R&D center of 14,500 square meters is a high-tech facility employing more than 200 employees.
With this new site, the company will be able to respond to the growing global demand for foot-and-mouth disease and Bluetongue virus control.
The 11th Expert Forum on Farm Animal Well-Being will bring together over 100 veterinary practitioners and welfare specialists.
World-class research & development facility of 3,300 square meters will help enhance China’s animal health industry.
Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targeting foot-and-mouth disease control and prevention in China.
Boehringer Ingelheim funds three research projects against swine disease PRRS with a total of €75,000
Investments in Athens, GA and St. Joseph, MO will enable increased capacity for companion animal and livestock vaccines.
Boehringer Ingelheim Animal Health sponsors the €75,000 research award programme in Europe both to encourage further development of practical methods for controlling PRRS and in order to recognise scientific excellence in this field.
New tool is part of suite of solutions to improve farm biosecurity and control of PRRS (Porcine Reproductive and Respiratory Syndrome).
Animal health business, following a positive 2016, is poised for strong long-term growth and industry leadership after strategic addition of Merial.
Biosecurity in pig farms plays a key role in PRRS control and some of the recommendations depend on the movement and flow of certain pathogen-carrying agents like people or objects.